The TERT promoter mutations −124 C > T and −146 C > T tend to be mutually exclusive and are reported to account for anywhere from 32% (based on NGS analysis of tissue [26]) to 68–78% (based on ddPCR analysis of tissue [39,40]) of all melanomas. This evidence concerns the gene TERT and melanoma.